Correction: Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
[This corrects the article DOI: 10.1371/journal.pmed.1002410.].
Main Authors: | Sanjay Basu, Jeremy B Sussman, Joseph Rigdon, Lauren Steimle, Brian T Denton, Rodney A Hayward |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-09-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1003785 |
Similar Items
-
Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
by: Sanjay Basu, et al.
Published: (2017-10-01) -
Black-White Cardiovascular Disease Disparities After Target-Based Versus Personalized Benefit–Based Lipid and Blood Pressure Treatment
by: Sanjay Basu MD, PhD, et al.
Published: (2017-08-01) -
Heterogeneity of Treatment Effects for Intensive Blood Pressure Therapy by Individual Components of FRS: An Unsupervised Data-Driven Subgroup Analysis in SPRINT and ACCORD
by: Yaqian Wu, et al.
Published: (2022-02-01) -
Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT
by: Cady Smith, et al.
Published: (2024-03-01) -
Sprinting After Having Sprinted: Prior High-Intensity Stochastic Cycling Impairs the Winning Strike for Gold
by: Naroa Etxebarria, et al.
Published: (2019-02-01)